Bitcoin's 7.14% jump to $69,300.01 is its biggest single-day gain in months and puts $70,000 back in play after a punishing year off the highs. Traders who wrote off the recovery now have a level to defend.
Bitcoin's 7.14% jump to $69,300.01 is its biggest single-day gain in months and puts $70,000 back in play after a punishing year off the highs. Traders who wrote off the recovery now have a level to defend.
Ethereum's 17.48% jump to $2,251.69 is its sharpest single-day gain in months, snapping it back above the $2,000 area it has churned around since spring. The prior close of $1,916.72 is now the level bulls need to hold.
The income a retiree creates before December 31 this year will show up in a Medicare bill two years from now, and crossing one invisible line by even a small amount can cost thousands more annually.
NEOS built its reputation on a flagship S&P 500 income ETF that clears 12% annually, but a pair of younger siblings run the same playbook at a noticeably different intensity, and the tradeoffs are not what most income investors expect.
With the Fed on hold and Treasury yields leaving income seekers shortchanged, four monthly-paying ETFs are engineering double-digit yields through very different mechanisms, and choosing the wrong one for your portfolio could cost you more than just upside.
Sponsored
_________________________________
Here's a question most people 5y from retirement can't answer: at your current savings rate, how much do you need, and how long will it actually last? A good advisor can put a date on that in a single meeting. SmartAsset's free quiz matches you with up to three fiduciary advisors serving your area, so you can get YOUR retirement number now (sponsor)
__________________________________________
Chevron lifted the quarterly payout 4.1% to $1.78 a share, a 26th straight year of increases holders lock in only by owning before the August 19 ex-date.
Coca-Cola cleared $90 for the first time, setting a fresh 52-week high at $90.35. Keep an eye on the stock at these levels.
Pfizer closed at $28.24, a new 52-week high that clears the April 1 peak. The drugmaker has now taken out the ceiling that capped it all spring, making that old level the line to defend.
AbbVie touched a new 52-week high at $265.97, clearing its July 29 peak. The $470 billion pharma has left its spring range near $200 behind.
Copper finished the session 2.21% higher at 273.93, a move big enough to matter for anyone holding miners or industrial names levered to the metal. Worth watching whether it holds into the next session.
Sponsored
Most Americans suspect they're behind on retirement and never find out. Advisor.com's free matching tool pairs you in about three minutes with a vetted fiduciary advisor who can help you with investing, taxes, retirement, estate planning, and more. No minimums. No sales call. Find out where you stand.
Original Medicare leaves three recurring bills entirely off the table, and most retirees discover the hard way that good intentions never filled a funding gap. Three ETFs built around different income engines may be exactly what your benefits statement is missing.
A $250,000 stake in a popular Treasury ETF is generating hundreds of dollars less per month than it did a year ago, yet the fund’s fee never budged. Understanding why that fixed cost quietly grows more expensive as rates fall changes the math on where you park serious cash.